Cyclin-Dependent Kinase 6 Phosphorylates NF-κB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Buss, Holger ^a   Handschick, Katja ^d   Jurrmann, Nadine ^b   Pekkonen, Pirita ^c   Beuerlein, Knut ^d   Müller, Helmut ^d   Wait, Robin ^e   Saklatvala, Jeremy ^e   Ojala, Päivi M ^c   Schmitz, M Lienhard ^f   Naumann, Michael ^b   Kracht, Michael ^d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF HELSINKI   (Finland)

^d JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 ACETYL 8 CYCLOPENTYL 5 METHYL 2 [5 (1 PIPERAZINYL) 2 PYRIDINYLAMINO] 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; CYCLIN D3; CYCLIN DEPENDENT KINASE 6; CYCLINE; SERINE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CATALYSIS; CELL STIMULATION; CHRONIC INFLAMMATION; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SPLEEN TUMOR; THYMOMA; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL NUCLEUS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 6; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; INFLAMMATION; LYMPHOCYTES; MICE; MICE, TRANSGENIC; NF-KAPPA B; PHOSPHORYLATION; RNA, SMALL INTERFERING; SERINE; SPLENIC NEOPLASMS; TANDEM MASS SPECTROMETRY; THYMUS NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

MUS MUSCULUS;

EID: 84871569843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051847     Document Type: Article

References (71)

1. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
2. Natoli G, Saccani S, Bosisio D, Marazzi I, (2005) Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6: 439-445.
3. Wietek C, O'Neill LA, (2007) Diversity and regulation in the NF-kappaB system. Trends Biochem Sci 32: 311-319.
4. Buss H, Dorrie A, Schmitz ML, Hoffmann E, Resch K, et al. (2004) Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279: 55633-55643.
5. Schmitz ML, Mattioli I, Buss H, Kracht M, (2004) NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 5: 1348-1358.
6. O'Shea JM, Perkins ND, (2010) Thr435 phosphorylation regulates RelA (p65) NF-kappaB subunit transactivation. Biochem J 426: 345-354.
7. Hoberg JE, Popko AE, Ramsey CS, Mayo MW, (2006) IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 26: 457-471.
8. Dong J, Jimi E, Zhong H, Hayden MS, Ghosh S, (2008) Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. Genes Dev 22: 1159-1173.
9. Geng H, Wittwer T, Dittrich-Breiholz O, Kracht M, Schmitz ML, (2009) Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep 10: 381-386.
10. Nowak DE, Tian B, Jamaluddin M, Boldogh I, Vergara LA, et al. (2008) RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol Cell Biol 28: 3623-3638.
11. Moreno R, Sobotzik JM, Schultz C, Schmitz ML, (2010) Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res 38: 6029-6044.
12. Barre B, Perkins ND, (2007) A cell cycle regulatory network controlling NF-kappaB subunit activity and function. EMBO J 26: 4841-4855.
13. Naugler WE, Karin M, (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19-26.
14. Vallabhapurapu S, Karin M, (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
15. Kaltschmidt B, Kaltschmidt C, Hehner SP, Droge W, Schmitz ML, (1999) Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 18: 3213-3225.
16. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr, (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799.
17. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, et al. (1999) NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19: 2690-2698.
18. Schneider G, Saur D, Siveke JT, Fritsch R, Greten FR, et al. (2006) IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression. EMBO J 25: 3801-3812.
19. Wolff B, Naumann M, (1999) INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB. Oncogene 18: 2663-2666.
20. Meyerson M, Faha B, Su LK, Harlow E, Tsai LH, (1991) The cyclin-dependent kinase family. Cold Spring Harb Symp Quant Biol 56: 177-186.
21. Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, et al. (2009) Cyclin-dependent kinases: a family portrait. Nat Cell Biol 11: 1275-1276.
22. Meyerson M, Harlow E, (1994) Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14: 2077-2086.
23. Lapenna S, Giordano A, (2009) Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov 8: 547-566.
24. Malumbres M, Barbacid M, (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30: 630-641.
25. Santamaria D, Barriere C, Cerqueira A, Hunt S, Tardy C, et al. (2007) Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448: 811-815.
26. Malumbres M, Barbacid M, (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166.
27. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, et al. (2004) Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118: 493-504.
28. Bockstaele L, Bisteau X, Paternot S, Roger PP, (2009) Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation. Mol Cell Biol 29: 4188-4200.
29. Grossel MJ, Hinds PW, (2006) Beyond the cell cycle: a new role for Cdk6 in differentiation. J Cell Biochem 97: 485-493.
30. Jung JU, Stager M, Desrosiers RC, (1994) Virus-encoded cyclin. Mol Cell Biol 14: 7235-7244.
31. Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, et al. (2000) The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2: 819-825.
32. Zhang L, Fried FB, Guo H, Friedman AD, (2008) Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. Blood 111: 1193-1200.
33. Sarek G, Jarviluoma A, Moore HM, Tojkander S, Vartia S, et al. (2010) Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency. PLoS Pathog 6: e1000818.
34. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, et al. (1996) Cyclin encoded by KS herpesvirus. Nature 382: 410.
35. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, et al. (1997) Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390: 184-187.
36. Kaldis P, Ojala PM, Tong L, Makela TP, Solomon MJ, (2001) CAK-independent activation of CDK6 by a viral cyclin. Mol Biol Cell 12: 3987-3999.
37. Phelps DE, Xiong Y, (1997) Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6. Methods Enzymol 283: 194-205.
38. Mattioli I, Sebald A, Bucher C, Charles RP, Nakano H, et al. (2004) Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. J Immunol 172: 6336-6344.
39. Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, et al. (1996) Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88: 2648-2654.
40. Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, et al. (2006) NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 107: 3295-3302.
41. Kress E, Gotta M, (2011) Aurora A in cell division: kinase activity not required. Nat Cell Biol 13: 638-639.
42. Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, et al. (2004) Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 3: 1427-1438.
43. Verschuren EW, Jones N, Evan GI, (2004) The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. J Gen Virol 85: 1347-1361.
44. Verschuren EW, Klefstrom J, Evan GI, Jones N, (2002) The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2: 229-241.
45. Verschuren EW, Hodgson JG, Gray JW, Kogan S, Jones N, et al. (2004) The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis. Cancer Res 64: 581-589.
46. Perkins ND, (2012) The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12: 121-132.
47. O'Shea JM, Perkins ND, (2008) Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans 36: 603-608.
48. Ortega S, Malumbres M, Barbacid M, (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87.
49. Wiedemeyer WR, Dunn IF, Quayle SN, Zhang J, Chheda MG, et al. (2010) Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proc Natl Acad Sci U S A 107: 11501-11506.
50. Hu MG, Deshpande A, Enos M, Mao D, Hinds EA, et al. (2009) A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Cancer Res 69 810-818: 0008-5472.
51. Nagel S, Leich E, Quentmeier H, Meyer C, Kaufmann M, et al. (2008) Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia 22: 387-392.
52. Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, et al. (2000) Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J 19: 3496-3506.
53. Rivadeneira DB, Mayhew CN, Thangavel C, Sotillo E, Reed CA, et al. (2010) Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterology 138: 1920-1930.
54. Ruas M, Gregory F, Jones R, Poolman R, Starborg M, et al. (2007) CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol Cell Biol 27: 4273-4282.
55. Anders L, Ke N, Hydbring P, Choi YJ, Widlund HR, et al. (2011) A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 20: 620-634.
56. Errico A, Deshmukh K, Tanaka Y, Pozniakovsky A, Hunt T, (2010) Identification of substrates for cyclin dependent kinases. Adv Enzyme Regul 50: 375-399.
57. Schmitz ML, dos Santos Silva MA, Altmann H, Czisch M, Holak TA, et al. (1994) Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. J Biol Chem 269: 25613-25620.
58. Cheung PC, Campbell DG, Nebreda AR, Cohen P, (2003) Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. EMBO J 22: 5793-5805.
59. Jones R, Ruas M, Gregory F, Moulin S, Delia D, et al. (2007) A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6. Cancer Res 67: 9134-9141.
60. Hu MG, Deshpande A, Schlichting N, Hinds EA, Mao C, et al. (2011) CDK6 kinase activity is required for thymocyte development. Blood 117: 6120-6131.
61. Adli M, Baldwin AS, (2006) IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J Biol Chem 281: 26976-26984.
62. Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, et al. (2004) Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem 279: 49571-49574.
63. Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, et al. (2008) Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132: 487-498.
64. Okazaki T, Sakon S, Sasazuki T, Sakurai H, Doi T, et al. (2003) Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem Biophys Res Commun 300: 807-812.
65. Koopal S, Furuhjelm JH, Jarviluoma A, Jaamaa S, Pyakurel P, et al. (2007) Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog 3: 1348-1360.
66. Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffmann E, et al. (1999) Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 19: 6742-6753.
67. Schweitzer K, Bozko PM, Dubiel W, Naumann M, (2007) CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. EMBO J 26: 1532-1541.
68. Tanaka T, Grusby MJ, Kaisho T, (2007) PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 8: 584-591.
69. Keller A, Nesvizhskii AI, Kolker E, Aebersold R, (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392.
70. Nesvizhskii AI, Keller A, Kolker E, Aebersold R, (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658.
71. Sarek G, Jarviluoma A, Ojala PM, (2006) KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 107: 725-732.